Christophe Arbet-Engels, MD, Q5: How Much Can Empagliflozin Lower A1c?

Dr. Christophe Arbet-Engels discusses the clinical results of the empagliflozin studies focusing on the A1c drops which varied by study and were anywhere from .7 to 1% depending on the patient. He also differentiates between A1c drops due to weight loss and those due to the excretion of excess glucose which can be difficult to tease apart.

Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

See more SGLT-2 Resources